A.R.T. Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-51,024
| Closed | -$196K | – | 1476 |
|
|
2019
Q2 | $196K | Buy |
51,024
+39,400
| +339% | +$151K | 0.01% | 1113 |
|
|
2019
Q1 | $59K | Sell |
11,624
-77,657
| -87% | -$394K | ﹤0.01% | 1206 |
|
|
2018
Q4 | $171K | Buy |
89,281
+67,355
| +307% | +$129K | 0.01% | 1095 |
|
|
2018
Q3 | $82K | Buy |
+21,926
| New | +$82K | ﹤0.01% | 1291 |
|
|
2018
Q2 | – | Sell |
-109,954
| Closed | -$262K | – | 1475 |
|
|
2018
Q1 | $262K | Sell |
109,954
-65,610
| -37% | -$156K | 0.01% | 1180 |
|
|
2017
Q4 | $686K | Buy |
175,564
+98,157
| +127% | +$384K | 0.03% | 772 |
|
|
2017
Q3 | $195K | Buy |
77,407
+65,000
| +524% | +$164K | 0.01% | 1141 |
|
|
2017
Q2 | $34K | Sell |
12,407
-38,800
| -76% | -$106K | ﹤0.01% | 1326 |
|
|
2017
Q1 | $99K | Sell |
51,207
-12,093
| -19% | -$23.4K | ﹤0.01% | 1270 |
|
|
2016
Q4 | $66K | Buy |
+63,300
| New | +$66K | ﹤0.01% | 1195 |
|
|
2016
Q3 | – | Sell |
-126,289
| Closed | -$89K | – | 741 |
|
|
2016
Q2 | $89K | Sell |
126,289
-99,239
| -44% | -$69.9K | ﹤0.01% | 1218 |
|
|
2016
Q1 | $263K | Buy |
225,528
+191,800
| +569% | +$224K | 0.01% | 1083 |
|
|
2015
Q4 | $82K | Buy |
+33,728
| New | +$82K | ﹤0.01% | 1347 |
|
|
2015
Q2 | – | Sell |
-92,100
| Closed | -$398K | – | 1509 |
|
|
2015
Q1 | $398K | Buy |
92,100
+56,058
| +156% | +$242K | 0.01% | 1003 |
|
|
2014
Q4 | $107K | Sell |
36,042
-26,039
| -42% | -$77.3K | ﹤0.01% | 1301 |
|
|
2014
Q3 | $206K | Buy |
+62,081
| New | +$206K | 0.01% | 1087 |
|